These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37674354)

  • 1. Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer.
    Chikaishi W; Higashi T; Hayashi H; Hanamatsu Y; Futamura M; Matsuhashi N; Saigo C; Takeuchi T
    Thorac Cancer; 2023 Oct; 14(30):3058-3062. PubMed ID: 37674354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon.
    Chikaishi W; Higashi T; Hayashi H; Hanamatsu Y; Kito Y; Futamura M; Matsuhashi N; Saigo C; Takeuchi T
    Thorac Cancer; 2023 Jul; 14(20):1941-1945. PubMed ID: 37220892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of IZUMO2 in the cell-in-cell phenomenon: A potential therapeutic target for triple-negative breast cancer.
    Higashi T; Saigo C; Chikaishi W; Hayashi H; Hanamatsu Y; Futamura M; Matsuhashi N; Takeuchi T
    Thorac Cancer; 2024 Mar; 15(7):513-518. PubMed ID: 38258402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.
    Huang P; Zhou X; Zheng M; Yu Y; Jin G; Zhang S
    Front Immunol; 2023; 14():1263537. PubMed ID: 37767092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin-expressing Treg facilitate T lymphocyte development in thymic nurse cell complexes.
    Zhang Y; Cao H; Chen J; Li Y; Xu A; Wang Y
    Commun Biol; 2021 Mar; 4(1):344. PubMed ID: 33727658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
    Sommaggio R; Cappuzzello E; Dalla Pietà A; Tosi A; Palmerini P; Carpanese D; Nicolè L; Rosato A
    Oncoimmunology; 2020 Jun; 9(1):1777046. PubMed ID: 32923140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells: Their role in triple-negative breast cancer progression and metastasis.
    Malla RR; Vasudevaraju P; Vempati RK; Rakshmitha M; Merchant N; Nagaraju GP
    Cancer; 2022 Mar; 128(6):1171-1183. PubMed ID: 34990009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer.
    Gao H; Tian Q; Zhou Y; Zhu L; Lu Y; Ma Y; Feng J; Jiang Y; Wang B
    Front Immunol; 2022; 13():904418. PubMed ID: 35774776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
    Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
    Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.
    Gibbs C; So JY; Ahad A; Michalowski AM; Son DS; Li Y
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.
    Fattori S; Le Roy A; Houacine J; Robert L; Abes R; Gorvel L; Granjeaud S; Rouvière MS; Ben Amara A; Boucherit N; Tarpin C; Pakradouni J; Charafe-Jauffret E; Houvenaeghel G; Lambaudie E; Bertucci F; Rochigneux P; Gonçalves A; Foussat A; Chrétien AS; Olive D
    Cancer Res; 2023 Sep; 83(18):3026-3044. PubMed ID: 37379438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
    Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
    Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer.
    Zhao Z; Li L; Du P; Ma L; Zhang W; Zheng L; Lan B; Zhang B; Ma F; Xu B; Zhan Q; Song Y
    Theranostics; 2019; 9(5):1401-1416. PubMed ID: 30867840
    [No Abstract]   [Full Text] [Related]  

  • 17. Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment.
    Bodenstine TM; Chandler GS; Reed DW; Margaryan NV; Gilgur A; Atkinson J; Ahmed N; Hyser M; Seftor EA; Strizzi L; Hendrix MJ
    Cell Cycle; 2016 May; 15(9):1295-302. PubMed ID: 27007464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1.
    Engel JB; Honig A; Kapp M; Hahne JC; Meyer SR; Dietl J; Segerer SE
    Arch Gynecol Obstet; 2014 Jan; 289(1):141-7. PubMed ID: 23828443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
    Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
    Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model.
    Kazemi MH; Shokrollahi Barough M; Ghanavatinejad A; Momeni-Varposhti Z; Khorrami S; Sadeghi B; Falak R
    Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):167-177. PubMed ID: 35490270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.